Drug Profile
Research programme: antiviral agents - Protarga
Alternative Names: Antiviral agents research programme - Protarga; Targaceutical® compoundsLatest Information Update: 04 Jan 2019
Price :
$50
*
At a glance
- Originator Luitpold Pharmaceuticals
- Class
- Mechanism of Action Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Herpesvirus infections; HIV infections
Most Recent Events
- 02 Jan 2019 Luitpold Pharmaceuticals is now called American Regent
- 19 Apr 2007 Discontinued - Preclinical for Herpesvirus infections in USA (unspecified route)
- 19 Apr 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)